PFIZER/WARNER-LAMBERT OPERATIONS IN THAILAND MERGE FOLLOWING FINAL FTC CLEARANCE IN THE U.S.

ข่าวทั่วไป Wednesday June 21, 2000 17:55 —PRESS RELEASE LOCAL

Bangkok--Jun 21--shandwick Thailand
PFIZER/WARNER-LAMBERT OPERATIONS IN THAILAND MERGE FOLLOWING FINAL FTC CLEARANCE IN THE U.S. Completion of the Merger Creates Fastest-Growing Major Pharmaceutical Company in Thailand
New Pfizer Combines Complementary Pharmaceutical Portfolios and a Powerful Sales and Marketing Capabilities
BANGKOK, June 21, 2000 - Pfizer International Corporation and Warner-Lambert Co. began the process of combining their operations in Thailand following final clearance by the Federal Trade Commission in the U.S. of their parent companies' proposed merger. Pfizer International's parent, Pfizer Inc., is based in New York, and Warner-Lambert's parent Warner-Lambert Co., is based in Morris Plains, N.J. Under the merger agreement, Pfizer Inc. is exchanging 2.75 shares of Pfizer common stock for each share of Warner-Lambert common in a tax-free transaction. The new company will have a market capitalization of $302 billion, fifth among the world's largest companies. The company estimates revenues of more than $31 billion for this year.
The combined operations in Thailand will be headed by Amal Naj, the current Country Manager of Pfizer International, who was appointed to the additional post of Managing Director for Warner-Lambert.
"As our Chairman William C. Steere, Jr., and President Dr. Hank McKinnell have said, this is a defining moment for Pfizer, and combining two of the fastest growing companies in the industry has created a global leader in the discovery of medicines," said Mr. Naj, Country Manager of Pfizer International.
- 2 -
"In Thailand, we will be combining two of the fastest growing and best companies in the pharmaceutical industry. The two companies' products are complementary, and so the business combination will create a new Pfizer International with the industry's deepest and broadest portfolio of medicines in Thailand. Its strongest presence will be in cardiovascular, cholesterol lowering, central nervous system illness, infectious disease, and Erectile Dysfunction or ED," said Mr. Naj.
"With the broader portfolio, we will be able to better server the patient and the medical community at large," he said. "And in the long run, patients and the medical community will benefit from the expanded research and development efforts resulting from the merger of the parent companies."
Mr. Naj cited that the parent company, Pfizer Inc., will spend $4.7 billion this year in research and development, the largest of any pharmaceutical company in the world. This and future such investments will be focused on creating new growth opportunities by the discovery of innovative therapies. The new Pfizer has more than 130 new product candidates in development to treat diseases and conditions, everything from cancer to common cold. "Many of these new discoveries would potentially be available for Thailand in the future," said Mr. Naj.
Citing directions offered by Dr. McKinnell, President of Pfizer, to affiliates around the world, Mr. Naj said Pfizer Thailand will move quickly to combine the operations of the two companies and that the process will be smooth and fast because of the complementary nature of their product lines and the remarkable similarities between the two companies, which already have proven record of working successfully as partners.
In Thailand, the business combination will double the size of Pfizer International. The company said it began the process of combining sales, marketing and medical activities. "Already, Pfizer and Warner-Lambert have two of the best field forces in the industry. The sales staff will be restructured into six teams, each focusing on a therapeutic portfolio of medicines. With our world-class training program and emphasis on core values, the new Pfizer International will set a new standard of excellence. It will be not just bigger, but better," said Mr. Naj.
Contact: Pongprach Surojnametakul [email protected] 662-257-0300 End.
-SS-

แท็ก marketing   thailand   Bangkok   central   nation   FED  

เว็บไซต์นี้มีการใช้งานคุกกี้ ศึกษารายละเอียดเพิ่มเติมได้ที่ นโยบายความเป็นส่วนตัว และ ข้อตกลงการใช้บริการ รับทราบ